Abstract
Asking “does an asbestos ban lead to a decrease in malignant mesothelioma?” is not a simple question as it may seem. This is largely because the phrase “asbestos ban” refers to a wide range of national situations and processes. It also reflects that countries have varied widely in their speed of reducing asbestos consumption in relation to, or independent of, adopting a ban. Thus, it is analytically complex to address an asbestos ban in relation to mesothelioma incidence, and few such studies have been conducted. The first study to directly address this question compared national-level data of changes in pleural mesothelioma mortality rates versus changes in asbestos use across a range of countries; the authors found correlations between these changes and suggested that there may be an early effect. The second study, which was a birth cohort analysis conducted in Sweden, showed that a later birth cohort (one active in the workforce after the decrease in asbestos use) had a decreased risk of pleural mesothelioma relative to an earlier birth cohort, regardless of gender. These studies implicated a causal effect, wherein an asbestos ban leads to a decrease in mesothelioma incidence. Given the very long latency period for mesothelioma, it can be expected that a much clearer effect will soon become evident in countries that adopted an early ban on asbestos. Furthermore, given the ongoing use of asbestos by many industrializing countries, it is also pertinent to ask: “Did an increase in mesothelioma incidence lead to an asbestos ban in some countries?”.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Forman D, Bray F, Brewster DH, Gombe MC, Kohler B, Piñeros M. Cancer incidence in five continents, vol. X. Lyon: International Agency for Research on Cancer; 2013.
Soeberg MJ, van Zandwijk N. Incidence of malignant mesothelioma in New Zealand and Australia: a global snapshot. N Z Med J. 2015;128(1427):68. https://www.nzma.org.nz/__data/assets/pdf_file/0007/46339/Soeberg-2020FINAL1427.pdf.
Zhao J, Zuo T, Zheng R, Zhang S, Zeng H, Xia C, et al. Epidemiology and trend analysis on malignant mesothelioma in China. Chin J Cancer Res. 2017;29(4):361. https://doi.org/10.21147/j.issn.1000-9604.2017.04.09.
World Health Organization (WHO). Mortality database health statistics and information systems. WHO: Geneva; 2018. https://www.who.int/healthinfo/mortality_data/en/.
Ajdacic-Gross V, Weiss MG, Ring M, Hepp U, Bopp M, Gutzwiller F, et al. Methods of suicide: international suicide patterns derived from the WHO mortality database. Bull World Health Organ. 2008;86:726–32. https://doi.org/10.2471/BLT.07.043489.
Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ. 2011;89:716–24. https://doi.org/10.2471/BLT.11.086678.
Le GV, Takahashi K, Park EK, Delgermaa V, Oak C, Qureshi AM, et al. Asbestos use and asbestos-related diseases in Asia: past, present and future. Respirology. 2011;16(5):767–75. https://doi.org/10.1111/j.1440-1843.2011.01975.x.
Kameda T, Takahashi K, Kim R, Jiang Y, Movahed M, Park EK, et al. Asbestos: use, bans and disease burden in Europe. Bull World Health Organ. 2014;92:790–7. https://doi.org/10.2471/BLT.13.132118.
Wikipedia, Global Disease Burden (GBD). https://en.wikipedia.org/wiki/Global_Burden_of_Disease_Study. Accessed 15 Oct 2019.
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60. https://doi.org/10.1016/S0140-6736(12)61766-8.
GBD 2013 Risk Factors Collaborators, Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287–323. https://doi.org/10.1016/S0140-6736(15)00128-2.
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. https://doi.org/10.1016/S0140-6736(14)61682-2.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–544. https://doi.org/10.1016/S0140-6736(16)31012-1.
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659–724. https://doi.org/10.1016/S0140-6736(16)31012-1.
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210. https://doi.org/10.1016/S0140-6736(17)32152-9.
GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345–422. https://doi.org/10.1016/S0140-6736(17)32366-8.
GBD 2017 Causes of Death Collaborators. Global, regional, and national age- sex- specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88. https://doi.org/10.1016/S0140-6736(18)32203-7.
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94. https://doi.org/10.1016/S0140-6736(18)32225-6.
Health and Safety Executive. Mesothelioma in Great Britain: Mesothelioma mortality in Great Britain 1968–2017. www.hse.gov.uk/statistics/causdis/mesothelioma/mesothelioma.pdf. Accessed 27 Oct 2019.
Mazurek JM, Syamlal G, Wood JM, Hendricks SA, Weston A. Morbidity and Mortality Weekly Report (MMWR): Malignant Mesothelioma Mortality—United States, 1999–2005. 2017. https://www.cdc.gov/mmwr/volumes/66/wr/mm6608a3.htm.
Soeberg MJ, Creighton N, Currow DC, Young JM, van Zandwijk N. Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972–2009. Aust N Z J Public Health. 2016;40(3):255–62. https://doi.org/10.1111/1753-6405.12503.
Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey BA, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90. https://doi.org/10.1016/S0140-6736(18)31694-5.
Driscoll T, Nelson DI, Steenland K, Leigh J, Concha-Barrientos M, Fingerhut M, et al. The global burden of disease due to occupational carcinogens. Am J Ind Med. 2005;48(6):419–31. https://doi.org/10.1002/ajim.20209.
Park EK, Takahashi K, Hoshuyama T, Cheng TJ, Delgermaa V, Le GV, et al. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect. 2011;119(4):514–8. https://doi.org/10.1289/ehp.1002845.
Odgerel CO, Takahashi K, Sorahan T, Driscoll T, Fitzmaurice C, Yoko-o M, et al. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. Occup Environ Med. 2017;74(12):851–8. https://doi.org/10.1136/oemed-2017-104298.
Kazan-Allen L. List of national asbestos bans by country. http://www.ibasecretariat.org/alpha_ban_list.php. Accessed 19 Oct 2019.
Commission Directive 1999/77/EC of 26 July 1999 adapting to technical progress for the sixth time Annex I to Council Directive 76/769/EEC on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (asbestos), OJ L 207, 6.8.1999, E. Union. 1999. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A31999L0077. Accessed 19 Oct 2019.
Allen L, Baez J, Stern M, Takahashi K, George F. Trends and the economic effect of asbestos bans and decline in asbestos consumption and production worldwide. Int J Environ Res Public Health. 2018;15(3):531. https://doi.org/10.3390/ijerph15030531.
Lin RT, Takahashi K, Karjalainen A, Hoshuyama T, Wilson D, Kameda T, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet. 2007;369(9564):844–9. https://doi.org/10.1016/S0140-6736(07)60412-7.
Nishikawa K, Takahashi K, Karjalainen A, Wen CP, Furuya S, Hoshuyama T, et al. Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment. Environ Health Perspect. 2008;116(12):1675–80. https://doi.org/10.1289/ehp.11272.
Järvholm B, Burdorf A. Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden. Scand J Public Health. 2015;43(8):875–81. https://doi.org/10.1177/1403494815596500.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Arachi, D., Soeberg, M., Chimed-Ochir, O., Lin, RT., Takahashi, K. (2021). Trend in the Global Incidence of Mesothelioma: Is There Any Changing Trend After Asbestos Regulation and Ban?. In: Nakano, T., Kijima, T. (eds) Malignant Pleural Mesothelioma. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-15-9158-7_1
Download citation
DOI: https://doi.org/10.1007/978-981-15-9158-7_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-9157-0
Online ISBN: 978-981-15-9158-7
eBook Packages: MedicineMedicine (R0)